JAMES B. HAWKINS - 01 Dec 2023 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
Director
Signature
/s/ James B. Hawkins
Issuer symbol
IRMD
Transactions as of
01 Dec 2023
Transactions value $
-$342,391
Form type
4
Filing time
05 Dec 2023, 16:30:30 UTC
Previous filing
01 Aug 2023
Next filing
11 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Award $37,338 +5,259 +14% $7.1* 41,821 01 Dec 2023 Direct F1
transaction IRMD Common Stock Sale -$227,593 -5,259 -13% $43.28 36,562 01 Dec 2023 Direct F2
transaction IRMD Common Stock Award $30,338 +4,273 +12% $7.1* 40,835 04 Dec 2023 Direct F1
transaction IRMD Common Stock Sale -$182,474 -4,273 -10% $42.7 36,562 04 Dec 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Stock Options (Right to Buy) Options Exercise $0 -5,259 -53% $0 4,741 01 Dec 2023 Common Stock 5,259 $7.1 Direct F1
transaction IRMD Stock Options (Right to Buy) Options Exercise $0 -4,273 -90% $0 468 04 Dec 2023 Common Stock 4,273 $7.1 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option, representing a right to purchase a total of 10,000 shares, was granted on 9-29-2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
F2 This transaction was executed in multiple trades at prices ranging from $42.70 to $43.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $42.70 to $42.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.